Diagnosis and Management of Rhinosinusitis: Highlights from the 2015 Practice Parameter
| Autor: | Anju T. Peters, Kathleen Dass |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Pulmonary and Respiratory Medicine
Allergy medicine.medical_specialty Immunology Physical examination Omalizumab Disease Antibodies Monoclonal Humanized 03 medical and health sciences 0302 clinical medicine medicine Humans Immunology and Allergy Nasal polyps Sinusitis 030223 otorhinolaryngology Glucocorticoids Rhinitis medicine.diagnostic_test business.industry Endoscopy Bacterial Infections medicine.disease Dermatology Anti-Bacterial Agents Surgery Acute Disease Chronic Disease Tomography X-Ray Computed business Mepolizumab 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Current Allergy and Asthma Reports. 16 |
| ISSN: | 1534-6315 1529-7322 |
| Popis: | Rhinosinusitis is a commonly diagnosed disease in the USA. Rhinosinusitis is classified as acute, recurrent, or chronic (with or without nasal polyps). While acute rhinosinusitis is diagnosed by history and physical examination, chronic rhinosinusitis and recurrent acute rhinosinusitis are diagnosed based on symptoms and the presence of disease on either a sinus CT scan and/or endoscopy. Management of uncomplicated acute rhinosinusitis includes analgesics, saline irrigation, and/or intranasal steroids. Antibiotics and intranasal steroids are recommended for acute bacterial rhinosinusitis. Intranasal and oral steroids with antibiotics are recommended to treat chronic rhinosinusitis although the evidence for antibiotics is weak. Biologics such as omalizumab and mepolizumab are being investigated for the treatment of chronic rhinosinusitis with nasal polyps. Surgery may be indicated in management of refractory chronic rhinosinusitis and rarely for acute bacterial rhinosinusitis. This review discusses highlights of the updated 2014 practice parameter and up-to-date evidence from other literature sources. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink